|
|
|
|
Keryx Biopharmaceuticals Announces Reversion of KRX-0401 (Perifosine) License Rights to Aeterna Zentaris ... More
Keryx Biopharmaceuticals Announces Positive Top-Line Results from Phase 3 Study of
Ferric Citrate (Zerenex(TM)) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical ... More
Keryx Biopharmaceuticals Announces Positive Top-Line Results from Phase 3 Study of
Ferric Citrate (Zerenex(TM)) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical ... More
Keryx maintains this website as a service to the Internet community. Access to and use of information presented on the Keryx website is subject to the terms and conditions described in "Use of the Keryx website".
Copyright © 2012 by Keryx Biopharmaceuticals, Inc.
Copyright © 2012 by Keryx Biopharmaceuticals, Inc.